A Comparative Phase I Study of Combination, Homologous Subtype-C DNA, MVA, and Env gp140 Protein/Adjuvant HIV Vaccines in Two Immunization Regimes

There remains an urgent need for a prophylactic HIV vaccine. We compared combined MVA and adjuvanted gp140 to sequential MVA/gp140 after DNA priming. We expected Env-specific CD4+ T-cells after DNA and MVA priming, and Env-binding antibodies in 100% individuals after boosting with gp140 and that com...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Immunol
Главные авторы: Joseph, Sarah, Quinn, Killian, Greenwood, Aldona, Cope, Alethea V., McKay, Paul F., Hayes, Peter J., Kopycinski, Jakub T., Gilmour, Jill, Miller, Aleisha N., Geldmacher, Christof, Nadai, Yuka, Ahmed, Mohamed I. M., Montefiori, David C., Dally, Len, Bouliotis, George, Lewis, David J. M., Tatoud, Roger, Wagner, Ralf, Esteban, Mariano, Shattock, Robin J., McCormack, Sheena, Weber, Jonathan
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2017
Предметы:
Immunology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5319954/
https://ncbi.nlm.nih.gov/pubmed/28275375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.00149
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы